There is a plethora of evidence available studying the association of risk profiles and the development of osteoporotic fractures. The small number of out-of-sample validations, the large variety of study characteristics, outcomes and follow-up periods impedes from deriving robust summaries and from conclusions regarding the clinical performance of many tools. First and foremost, future activity in this field should aim at reaching a consensus among clinical experts in respect to the existing instruments. Then we call for careful validations and expedient adaptations for local circumstances of the most promising candidates
SummaryWe describe the collection of cohorts together with the analysis plan for an update of the fr...
Introduction: Osteoporosis has been recognised as an established and well-defined disease that affec...
SUMMARY: A Swiss-specific FRAX model was developed. Patient profiles at increased probability of fra...
BACKGROUND: With the broad availability of effective medications, identifying individuals bearing a ...
With the broad availability of effective medications, identifying individuals bearing a higher risk ...
Summary: A Swiss-specific FRAX® model was developed. Patient profiles at increased probability of fr...
Abstract Background Today, while there are effective drugs that reduce the risk of osteoporotic frac...
Decision aids (DAs) are evidence-based tools that support shared decision-making (SDM) implementatio...
We describe the collection of cohorts together with the analysis plan for an update of the fracture ...
We aimed to develop and validate the FRActure Health Search (FRA-HS) score for prediction of risk of...
We aimed to develop and validate the FRActure Health Search (FRA-HS) score for prediction of risk of...
The study aimed to investigate the effectiveness of the clinical use of the Fracture Risk Assessment...
Object of research: Women in whom the risk of osteoporotic fractures was assessed using the FRAX, Q-...
OBJECTIVES: The aim of this study was to conduct a systematic review and meta-analysis on the perfor...
Summary: We describe the collection of cohorts together with the analysis plan for an update of the ...
SummaryWe describe the collection of cohorts together with the analysis plan for an update of the fr...
Introduction: Osteoporosis has been recognised as an established and well-defined disease that affec...
SUMMARY: A Swiss-specific FRAX model was developed. Patient profiles at increased probability of fra...
BACKGROUND: With the broad availability of effective medications, identifying individuals bearing a ...
With the broad availability of effective medications, identifying individuals bearing a higher risk ...
Summary: A Swiss-specific FRAX® model was developed. Patient profiles at increased probability of fr...
Abstract Background Today, while there are effective drugs that reduce the risk of osteoporotic frac...
Decision aids (DAs) are evidence-based tools that support shared decision-making (SDM) implementatio...
We describe the collection of cohorts together with the analysis plan for an update of the fracture ...
We aimed to develop and validate the FRActure Health Search (FRA-HS) score for prediction of risk of...
We aimed to develop and validate the FRActure Health Search (FRA-HS) score for prediction of risk of...
The study aimed to investigate the effectiveness of the clinical use of the Fracture Risk Assessment...
Object of research: Women in whom the risk of osteoporotic fractures was assessed using the FRAX, Q-...
OBJECTIVES: The aim of this study was to conduct a systematic review and meta-analysis on the perfor...
Summary: We describe the collection of cohorts together with the analysis plan for an update of the ...
SummaryWe describe the collection of cohorts together with the analysis plan for an update of the fr...
Introduction: Osteoporosis has been recognised as an established and well-defined disease that affec...
SUMMARY: A Swiss-specific FRAX model was developed. Patient profiles at increased probability of fra...